The NX One platform is the first universally adoptable system to characterize, sort, and isolate single cells from biological samples - Industry veteran William Rhodes joins Board of Directors SAN JOSE, Calif. -- Nodexus Inc., an emerging leader in the development of automated live cell characterization and isolation technologies, has raised an oversubscribed $30M Series A financing [...]

STATESVILLE, N.C.—  Kewaunee Scientific Corporation (NASDAQ: KEQU), a recognized global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, today announces that the Company’s Indian subsidiary has been awarded a significant turnkey contract from Laurus Synthesis (https://laurussynthesis.com), a subsidiary of Laurus Labs. Laurus Synthesis is a leading Contract Development & [...]

The Carl Zeiss AG shareholders' meeting has appointed Dr. Michael Bolle the new Supervisory Board member to represent the sole shareholder the Carl Zeiss Foundation. He will be elected Chairman of the Supervisory Board of Carl Zeiss AG in January 2022. Dr. Bolle will succeed Dr. Dieter Kurz, whose mandate as Chairman of the Supervisory [...]

Tissue biopsies with tumor cell contents that are too low for conventional testing methods can now be rescued due to the ability of MSB’s DEPArray technology* to successfully recover low numbers of tumor cells from these difficult samples. The new FFPE Rescue Application* will provide pathology labs with a validated workflow to identify potentially targetable [...]

Oxford expansion supports U.K. customers with fast turnaround time on research products, and technical support OXFORD, England --GenScript Biotech Corp., a global biotechnology group, announced today that it has expanded operations in the United Kingdom with new offices and a fully functional logistics center in Oxford. The facility supports U.K. customers with fast delivery of [...]

HERCULES, Calif.– Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the appointment of Simon May as Executive Vice President and President of the Life Science Group, effective January 4, 2022. He succeeds Annette Tumolo who will retire from this role at that time. Dr. [...]

Männedorf, Switzerland – Tecan Group Ltd. (SIX Swiss Exchange: TECN) announced today that its Board of Directors will propose the election of Myra Eskes as a new independent member of the Board at Tecan’s next Annual General Meeting on April 12, 2022. Tecan, a pioneer and global leader in laboratory automation for life sciences and diagnostics, expanded into the medical devices sector with the acquisition of Paramit Corporation in August 2021. With more than [...]

NEXT-GENERATION SEQUENCING PLATFORM WILL PROVIDE UP TO THREE TIMES MORE DATA OUTPUT PER HOUR THAN OTHER BENCHTOP INSTRUMENTS, WHILE OFFERING FLEXIBLE RUN CAPACITY – LA JOLLA, Calif. -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the commercial launch of [...]

Collaboration aims to combine Twist’s proprietary synthetic antibody libraries and sophisticated bioinformatics expertise with Sosei Heptares’ world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR targets SOUTH SAN FRANCISCO, Calif.--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, [...]

The life science group Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated Lab Solutions GmbH. The laboratory technology company based in Jena, Germany, develops, manufactures and markets solutions for the automated analysis, selection and isolation of cells. With these solutions, ALS enables life science customers to significantly reduce time [...]